Related Experiment Video
Updated: Sep 9, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Performance of Different Versions of Duke Criteria in Diagnosing Infective Endocarditis in Patients With Intracardiac
Matthaios Papadimitriou-Olivgeris1,2, Bruno Ledergerber3, Jana Epprecht3
1Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Insights
The 2023 ISCVID Duke criteria show higher sensitivity for diagnosing infective endocarditis (IE) in patients with prosthetic material than older ESC criteria. However, this improved detection comes with reduced specificity.
Area of Science:
- Cardiology
- Infectious Diseases
- Clinical Diagnostics
Background:
- Diagnosing infective endocarditis (IE) presents significant clinical challenges.
- Intracardiac prosthetic material complicates IE diagnosis.
- Evaluating updated clinical criteria is crucial for accurate IE detection.
Purpose of the Study:
- Compare diagnostic performance of 2015 ESC, 2023 ESC, and 2023 ISCVID Duke criteria.
- Assess criteria in patients with suspected IE and prosthetic material.
- Determine the most sensitive and specific diagnostic approach.
Main Methods:
- Retrospective study at two Swiss University Hospitals (2014-2024).
- Reference standard: Endocarditis Team/expert clinician diagnosis.
- Evaluated 1025 suspected IE episodes with intracardiac prosthetic material.
Main Results:
- The 2023 ISCVID Duke criteria identified 42% of definite IE cases, higher than 2015 ESC (32%) and 2023 ESC (36%).
- Sensitivity: 2023 ISCVID (71%) > 2023 ESC (61%) > 2015 ESC (56%).
- Specificity: 2015 ESC (67%) > 2023 ESC (56%) > 2023 ISCVID (34%).
Conclusions:
- The 2023 ISCVID Duke criteria offer superior sensitivity for IE diagnosis in prosthetic material patients.
- This increased sensitivity is associated with a notable decrease in specificity.
- Clinical application requires balancing sensitivity and specificity based on patient context.
Background:
Diagnosing infective endocarditis (IE) is a significant challenge. This study aimed to compare the diagnostic performance of the 2015 and 2023 European Society of Cardiology (ESC) and the 2023 International Society for Cardiovascular Infectious Diseases (ISCVID) Duke clinical criteria in a cohort of patients with suspected IE and intracardiac prosthetic material.
Methods:
This retrospective study was conducted at 2 Swiss University Hospitals (2014-2024). The reference standard was the diagnosis of the Endocarditis Team or expert clinicians. Patients with IE (reference standard) classified as definite IE by the Duke criteria were considered true positives, while those without IE classified as rejected IE were considered true negatives.
Results:
Of the 1025 episodes with suspected IE and intracardiac prosthetic material, 537 (61%) had IE. Using the 2015 ESC, 2023 ESC, and 2023 ISCVID clinical criteria, 324 (32%), 367 (36%), and 430 (42%) episodes were classified as definite IE, respectively. The sensitivity for the 2015 Duke-ESC, 2023 Duke-ESC, and 2023 Duke-ISCVID the clinical criteria was calculated to be 56% (95% CI: 52-60%), 61% (57-65%), and 71% (67-74%), respectively, while the specificity 67% (63-71%), 56% (51-61%), and 34% (29-38%), respectively.
Conclusions:
The 2023 ISCVID Duke clinical criteria demonstrated the highest sensitivity for diagnosing IE compared to the 2015 and 2023 ESC Duke criteria in patients with intracardiac prosthetic material. However, this was at the expense of specificity.
Related Concept Videos
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests

